On the 4th, AriBio Lab decided to acquire 5 billion won in face value of AriBio's 26th CB issue for 10 billion won. The counterparty is AMS Holdings, the existing CB holder. The bonds carry a surface coupon of 0% and a maturity yield of…
Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transaction may contain terms that could limit superior competing offers. Shareholders are encouraged to contact the firm to discuss their rights and options at no…
F5, Inc. (NASDAQ:FFIV - Get Free Report) CTO Kunal Anand sold 1,989 shares of the company's stock in a transaction dated Tuesday, November 3rd. The shares were sold at an average price of $324.06, for a total transaction of $644,555.34. Following the transaction, the chief…
Denali Therapeutics (DNLI) released third quarter 2026 results that swung to a profit and were driven by stronger than expected AVLAYAH sales, alongside fresh revenue guidance for the fourth quarter. Scan beyond Denali Therapeutics and evaluate other potential opportunities in rare…
Kalkine Media On November 4, 2026, FMR LLC and Abigail P. Johnson submitted Amendment No. 3 to their Schedule 13G filing with the SEC, reporting their beneficial ownership of Roblox Corp Class A Common Stock as of September 30, 2026. Through Amendment No. 3 to Schedule 13G, FMR LLC…
New data shows more than 5 million Texans don’t have health insurance, including about 1 million children – but advocates warn the numbers doesn’t reflect policy changes that have led to more people losing coverage. The U.S. Census Bureau recently published data…
Yahoo Finance Oops, something went wrong U.S. markets open in 7h 8m Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and…
FSSA will host webinar town halls to help HIP members, providers and community partners learn more about the upcoming HIP Work Requirements. The first webinar will be Friday, Nov. 6 at 9 a.m. CT / 10 a.m. ET with additional webinars to be announced. The webinars…
- Phase 1 monotherapy data update in metastatic colorectal cancer (mCRC) expected in January 2027 - - Phase 1 study in combination with bevacizumab in 3L+ mCRC ongoing. Phase 1/2 chemotherapy combination study in 2L mCRC expected to be initiated by year-end - - Phase 1 Varseta-M monotherapy expansion cohorts for gastric…
/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of EyePoint, Inc. ("EyePoint" or the "Company") (NASDAQ: EYPT). Such investors are... NEW YORK, Nov. 5, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of EyePoint, Inc. ("EyePoint" or…
Hospitals, clinics, payers, med‑tech, telehealth, and healthcare services delivery.
An article joins this feed when it matches these terms. Each one is also a search of its own.